Sathyan A, Mohanapriya M, Madhanraja R, Indu Vadana KS, Indhuja K, Sumathi P, et al. A Comprehensive Review of Evidence and Challenges in Switching from Originator Drugs to Biosimilars of Monoclonal Antibodies: Focus on Rituximab and Trastuzumab. J. Drug Delivery Ther. [Internet]. 2025 Feb. 15 [cited 2026 Jun. 2];15(2):149-55. Available from: https://jddtonline.info/index.php/jddt/article/view/7012